Early Clinical Evaluation of Potential Synergy of Targeted Radiotherapy with Lintuzumab-Ac225 and Venetoclax in Relapsed/Refractory AML Article

Full Text via DOI: 10.1182/blood-2022-157588 Web of Science: 000893223203163

Cited authors

  • Schiller GJ, Finn L, Hegazi MM, Orozco JJ, Desai A, Chen MM, Roboz GJ

Authors

Publication date

  • 2022

Published in

International Standard Serial Number (ISSN)

  • 0006-4971

Number of pages

  • 2

Start page

  • 3336

End page

  • 3337

Volume

  • 140